CD40 SIGNAL TRANSDUCTION
CD40 SIGNAL TRANSDUCTION
批准号:
2403569
负责人:
VISHVA M DIXIT
金额:
$16.24万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-08-01 至 2000-07-31
中文摘要
描述:(改编自研究者的摘要)CD40是一个细胞
英文摘要
DESCRIPTION: (adapted from the investigator's abstract) CD40 is a cell
surface transmembrane 45kDa glycoprotein receptor expressed on B-
lymphocytes. CD40 activation is critical for B-cell proliferation,
immunoglobulin class switching. NfkB activation and rescue of germinal
center B-cells from apoptosis following somatic mutation. Resistance
to apoptosis is conferred by the induction of the anti-death gene
product, Bcl-x. CD40 is a member of the tumor necrosis factor receptor
family and, like other members, it appears to possess no intrinsic
signalling capacity (e.g. kinase activity), suggesting that signal
transduction is likely mediated by associating molecules. To identify
such molecules, the yeast two hybrid system was used to clone cDNAs
encoding proteins that bind to the CD40 cytoplasmic domain. One such
interacting protein, designated CD40-binding protein (CD40bp), has a N-
terminal RING finger motif and a prominent central coiled-coil segment
that may allow homo- or hetero-oligomerization. Significantly, the C-
terminus possesses substantial homology to the tumor necrosis factor
receptor-associated factor (TRAF) domain that is found in two proteins
(TRAF1 and TRAF2) that associate with the cytoplasmic domain of the
related 75kD tumor necrosis factor receptor. Dominant-negative CD40bp
inhibited the induction of Bcl-x in response to CD40 activation
suggesting an important role in signaling. The second CD40 interacting
protein identified was TRAF2, over- expression of which resulted in the
activation of NF-kB. Notably, dominant- negative TRAF2 completely
abrogated the activation of NfkB by CD40, confirming that TRAF2 couples
the receptor to the NF-k B pathway. It is the intention of this grant
application to capitalize on these findings. The following Specific
Aims will be undertaken. Specific Aim 1: Confirm that endogenous CD40bp
and TRAF2 bind CD40 in a ligand dependent fashion and that the TRAF
domain is indeed responsible for receptor association. Specific Aim 2:
Use the yeast two-hybrid and complementary biochemical approaches to
clone and characterize CD40bp and TRAF2 interacting proteins. Specific
Aim 3: Determine if CD40bp and TRAF2 modulate other CD40 signaling
events including activation of cytoplasmic src-like kinases and PI3
kinase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
B61 IN INFLAMMATION AND DEVELOPMENT
-
批准号:6238938
-
项目类别:
-
资助金额:$4.83万
-
财政年份:1997
-
负责人:VISHVA M DIXIT
-
依托单位:
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
-
批准号:2430280
-
项目类别:
-
资助金额:$21.43万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
SIGNAL TRANSDUCTION BY THE ECK RECEPTOR TYROSINE KINASE
-
批准号:2152830
-
项目类别:
-
资助金额:$20.6万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
FAS ASSOCIATED DEATH DOMAIN (FADD)
-
批准号:2376204
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
CD40 SIGNAL TRANSDUCTION
-
批准号:2207431
-
项目类别:
-
资助金额:$19.42万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
FAS ASSOCIATED DEATH DOMAIN (FADD)
-
批准号:2055674
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1996
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2443110
-
项目类别:
-
资助金额:$20.11万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107491
-
项目类别:
-
资助金额:$18.2万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107493
-
项目类别:
-
资助金额:$19.49万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
ERB-B-2 EXPRESSION AND RESISTANCE TO TNF KILLING
-
批准号:2107492
-
项目类别:
-
资助金额:$18.84万
-
财政年份:1994
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102090
-
项目类别:
-
资助金额:$27.09万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102089
-
项目类别:
-
资助金额:$25.98万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:3204813
-
项目类别:
-
资助金额:$24.05万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
NOVEL ZINC FINGER PROTEIN THAT INHIBITS TNF CYTOTOXICITY
-
批准号:2102088
-
项目类别:
-
资助金额:$24.51万
-
财政年份:1993
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2; STRUCTURE EXPRESSION AND FUNCTION
-
批准号:3202426
-
项目类别:
-
资助金额:$25.14万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2; STRUCTURE EXPRESSION AND FUNCTION
-
批准号:3202427
-
项目类别:
-
资助金额:$21.13万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
-
批准号:2098861
-
项目类别:
-
资助金额:$25.25万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
-
批准号:2098862
-
项目类别:
-
资助金额:$26.23万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
HEPARIN AND AORTIC SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:3367033
-
项目类别:
-
资助金额:$13.49万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
THROMBOSPONDIN 2--STRUCTURE EXPRESSION AND FUNCTION
-
批准号:2098863
-
项目类别:
-
资助金额:$27.92万
-
财政年份:1992
-
负责人:VISHVA M DIXIT
-
依托单位:
海外基金